Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Return on Assets (2016 - 2025)

Historic Return on Assets for Fate Therapeutics (FATE) over the last 13 years, with Q3 2025 value amounting to 0.45%.

  • Fate Therapeutics' Return on Assets fell 1000.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.41% for FY2024, which is 1200.0% down from last year.
  • Per Fate Therapeutics' latest filing, its Return on Assets stood at 0.45% for Q3 2025, which was down 1000.0% from 0.46% recorded in Q2 2025.
  • Fate Therapeutics' Return on Assets' 5-year high stood at 0.15% during Q2 2021, with a 5-year trough of 0.46% in Q2 2025.
  • Its 5-year average for Return on Assets is 0.34%, with a median of 0.35% in 2024.
  • In the last 5 years, Fate Therapeutics' Return on Assets surged by 1900bps in 2021 and then plummeted by -2200bps in 2022.
  • Fate Therapeutics' Return on Assets (Quarter) stood at 0.23% in 2021, then tumbled by -84bps to 0.42% in 2022, then rose by 21bps to 0.33% in 2023, then decreased by -25bps to 0.41% in 2024, then decreased by -10bps to 0.45% in 2025.
  • Its Return on Assets stands at 0.45% for Q3 2025, versus 0.46% for Q2 2025 and 0.44% for Q1 2025.